Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose inhaled nitric oxide versus placebo for acute chest syndrome in adults with sickle cell disease
2006-006377-24Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute chest syndrome (ACS) and sickle cell disease (SCD) comparing High-dose inhaled nitric oxide with Placebo (2 arms). Started Nov 2007; status: completed.
02
Drugs
nitric oxide
03
Conditions
acute chest syndrome (ACS)sickle cell disease (SCD)
Beyond the preview
Go deeper on 2006-006377-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006377-24.